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 Abstract    
Aim of the paper: Comparison of conventional cytodiagnostics with molecular identification of DNA and mRNA 
HPV HR, immunocytochemical test for suppressor protein P16 and nuclear Ki 67 to detect cervical pathology scre-
ening of the division to LG SIL and HG SIL.
Material: 630 Pap smears were taken from women with suspected cervical pathology  were submitted for analysis, 
together with 558 smears for the presence of DNA HPV HR, 421 swabs for the presence of mRNA HPV HR,  86 
swabs for the presence of suppressor protein P16 and nuclear Ki 67. In all of the women standard colposcopy with 
biopsy and endocervical abrasion were performed.
Method: The study used a classic cytological smear, taken on the slide, rated in accordance with TBS classi-
fication, colposcopy implemented in accordance with the guidelines of the International Federation of Cervical 
Pathology and Colposcopy from 2003, molecular diagnostic tests based on identifying DNA, mRNA HPV HR and 
immunocytochemistry diagnostic test – CINtecPLUSTM.
Results: The sensitivity of Pap test identification of CIN 2 + was of 85% and specificity of 23%. Indicators PPV and 
NPV were respectively 39% and 72%. The accuracy of cytology reached a level of 46%. DNA HPV HR test obtained 
91% sensitivity and 33% specificity of the diagnosis of CIN 2 +. Its accuracy was 54%. The value of PPV and NPV 
for molecular diagnostics was respectively 43% and 87%. For mRNA HPV HR test sensitivity of the method was 
79%, the specificity was 67%.  CINTecPLUSTM test achieved 100% sensitivity and 67% specificity in the diagnosis 
of CIN 2 +.
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Introduction
Population-based	 prevention	 programs	 for	 cervical	 cancer	
brought	 tangible	 results	 in	 the	 reduction	 of	 morbidity	 and	
mortality	in	women.	However,	implementation	of	these	programs	
over	the	past	decade	has	proved	that	a	nearly	100%	reportability	to	
research	and	repeat	at	intervals	of	3-5	years,	does	not	completely	
eliminate	the	incidence	of	cervical	cancer.	Particularly	disturbing	
is	occasional	detection	of	cervical	cancer	in	women	who	have	had	
regular	Pap	tests.	The	cause	of	this	problem	is	the	relatively	low	
sensitivity	of	cytodiagnostics	and	low	efficiency	of	this	method	in	
identifying	pathology	of	glandular	epithelium	of	the	cervix.	
Currently	there	is	a	need	for	new	diagnostic	tests	that	would	
either	 supplement	 or	 replace	 cytodiagnostics	 as	 a	 screening	
tool.	 These	 methods	 should	 comply	 with	 WHO	 standards	
specified	 for	 screening	 tests,	 be	 competitive	with	 conventional	
cytodiagnostics	and	levied	on	liquid	based	cytology	(LBC)	in	the	
detection	of	precancerous	lesions,	squamous	cervical	cancer	and	
adenocarcinoma.	
According	to	the	current	views	the	main	purpose	of	screening	
is	 to	 detect	 changes	 known	 as	HG	 SIL	 (high	 grade	 squamous	
intraepithelial	lesion),	which	correspond	in	terms	of	histological	
view	with	CIN	2	+	and	the	identification	of	LG	SIL	(low	grade	
squamous	 intraepithelial	 lesion)	 or	 CIN	 1	 being	 exponent	 of	
infection	with	oncogenic	types	of	HPV.
According	to	new	methods	such	as	molecular	tests	for	DNA	
and	mRNA	HPV	HR	and	immunocytochemical	tests	of	suppressor	
protein	P16	and	nuclear	Ki	67	 involved	 in	 the	development	of	
CIN,	sensitivity	and	accuracy	of	diagnostic	tests	resembling	the	
final	histopathological	diagnosis	are	most	important.
Aim of the paper
Comparison	of	conventional	cytodiagnostics	with	molecular	
identification	of	DNA	and	mRNA	HPV	HR,	immunocytochemical	
tests	for	P16	and	Ki67	to	detect	cervical	pathology	screening	of	
the	division	to	LG	SIL	and	HG	SIL.
Materials
The	 study	 included	 630	 women	 aged	 25-65	 years	 (mean	
45	years	+	/-SD)	directed	for	further	diagnostics	because	of	the	
extensive	evaluation	of	abnormal	Pap	smears	performed	 in	 the	
screening.	
Conclusions: 
1. Conventional cytodiagnostics are inferior in terms of both sensitivity and specificity of molecular test for DNA, 
mRNA HPV HR  and immunocytochemical test for detecting of LG SIL and HG SIL.
2. Immunocytochemical technique shows maximum sensitivity and high specificity of detection of actual 
precancerous  stages - CIN 2 +.
 Key words: cervical intraepithelial neoplasia / DNA HR HPV / mRNA HPV HR / 
        / cytodiagnostics / immunocytochemistry / prevention / P16 / Ki67 / 
 Streszczenie
Cel pracy: Porównanie konwencjonalnej cytodiagnostyki z identyfikacją molekularną DNA HPV HR i mRNA HPV 
HR oraz immunocytochemicznym testem na wykrywanie białek supresorowych P16 i jądrowego Ki67 pod kątem 
wykrywania patologii szyjki macicy w skriningu z podziałem na rozpoznania histopatologiczne LG SIL i HG SIL.
Materiał: Analizie poddano 630 wymazów cytologicznych pobranych od kobiet z podejrzeniem patologii szyjki 
macicy, 558 wymazów na obecność DNA HPV HR, 421 wymazów na obecność mRNA HPV HR, 86 wymazów 
na obecność białek supresorowych P16 i jądrowego Ki67. U wszystkich badanych kobiet wykonano standardowe 
badanie kolposkopowe z pobraniem wycinków i abrazję kanału szyjki macicy.
Metoda: W badaniach wykorzystano klasyczny wymaz cytologiczny pobierany na szkiełko podstawowe oceniany 
wg klasyfikacji TBS, kolposkopię realizowaną zgodnie z wytycznymi Międzynarodowej Federacji Patologii Szyjki 
Macicy i Kolposkopii z roku 2003, diagnostykę molekularną opartą o testy identyfikujące DNA i mRNA HPV HR oraz 
diagnostykę immunocytochemiczną, czyli test CINTecPLUSTM.
Wyniki: Czułość badania cytologicznego identyfikującego zmiany CIN 2+ wyniosła 85%, a specyficzność 23%. 
Wskaźniki PPV i NPV wyniosły odpowiednio 39% i 72%. Dokładność cytologii osiągnęła poziom 46%. Test DNA 
HPV HR uzyskał 91% czułość i 33% specyficzność w diagnostyce zmian CIN 2+. Jego dokładność wyniosła 
54%. Wartość PPV i NPV dla diagnostyki molekularnej wyniosła odpowiednio 43% i 87%. Dla mRNA HPV czułość 
metody wyniosła 79%, specyficzność 67%. Test CINTecPLUSTM osiągnął 100% czułość i 67% swoistość w roz-
poznawaniu CIN 2+. 
Wnioski: 
1. Cytodiagnostyka konwencjonalna ustępuje pod względem czułości i swoistości zarówno testom molekularnym 
DNA HPV jak i technice immunocytochemicznej w procesie wykrywania LG SIL i HG SIL. 
2. Maksymalną czułość i wysoką swoistość wykrywania rzeczywistych stanów przedrakowych czyli zmian CIN 2+ 
wykazuje technika immunocytochemiczna. 
 Słowa kluczowe: śródnabłonkowa neoplazja / DNA HPV HR / mRNA HPV HR / 
      / cytodiagnostyka / immunocytochemia / profilaktyka / P16 / Ki67 / 
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Table I. Statistical analysis of the relation between the final histopathological results and PAP test, DNA HPV HR test, mRNA HPV HR test and  CINtecPLUSTM , p <0.05.
Type of study Result
Histopathological result Statisticals
analysisStandard LG SIL HG SIL
PAP test
Standard 51 (23,0%) 39 (14,1%) 20 (15,3%)
Χ2=69,7
p<0,00001
V = 0,24
ASC-US 102 (45,9%) 87 (31,4%) 33 (25,2%)
LSIL 61 (27,5%) 139 (50,2%) 52 (39,7%)
HSIL 8 (3,6%) 12 (4,3%) 26 (19,8%)
PAT 171 (77,0%) 238 (85,9%) 111 (84,7%)
DNA
HPV HR test
Positive 140 (67,0%) 212 (91,4%) 107 (91,5%) Χ2=53,41
P<0,00001
V = 0,31Negative 69 (33,0%) 20 (8,6%) 10 (8,5%)
mRNA
HPV HR test
Positive 42(33,3%) 148(69,5%) 65(79,3%) Χ=58,23
P<0,00001
V = 0,37Negative 84(66,7%) 65(30,5%) 17(20,7%)
CINtecPLUS
(P16 Ki 67)
Positive 10(33,3%) 11(47,8%) 15(100%) Χ2=18,20
P=0,0001
V = 0,52
Table III. The values of sensitivity (SENS), specificity (SPEC), positive (PPV) and negative (NPV) predictive value and accuracy (ACC) as well as reliability indicators  
(LR +, LR-) for PAP test, DNA HPV HR test, mRNA HPV HR test and  CINtecPLUSTM  in women with HG SIL.
HG SIL TP FP FN TN SENS(%)
SPEC
(%) LR+ LR-
PPV
(%)
NPV
(%)
ACC
(%)
ASC-US 33 102 20 51 62 33 0,93 1,13 24 72 41
HSIL 26 8 20 51 57 86 4,17 0,50 76 72 73
LSIL 52 61 20 51 72 46 1,33 0,61 46 72 56
PAPA 111 171 20 51 85 23 1,10 0,66 39 72 46
DNA HPV 107 140 10 69 91 33 1,37 0,26 43 87 54
mRNA HPV 65 42 17 84 79 67 2,38 0,31 61 83 72
CINtecPLUS 15 10 0 20 1,00 67 3,00 0,00 60 100 78
Table II. The values of sensitivity (SENS), specificity (SPEC), positive (PPV) and negative (NPV) predictive value and accuracy (ACC) as well as reliability indicators (LR +, LR-) 
for PAP test, DNA HPV HR test, mRNA HPV HR test and  CINtecPLUSTM  in women with LG SIL. Abbreviations in the table are as follows: TP- true positive results, FP-false 
positive results, FN false-negative results, TP true-negative results.
LG SIL TP FP FN TN SENS(%)
SPEC
(%) LR+ LR-
PPV
(%)
NPV
(%)
ACC
(%)
ASC-US 87 102 39 51 69 33 1,04 0,93 46 57 49
HSIL 12 8 39 51 24 86 1,74 0,88 60 57 57
LSIL 139 61 39 51 78 46 1,43 0,48 70 57 66
PAPA 238 171 39 51 86 23 1,12 0,61 58 57 58
DNA HPV 212 140 20 69 91 33 1,36 0,26 60 78 64
mRNA HPV 148 42 65 84 69 67 2,08 0,46 78 56 68
CINTecPLUS 11 10 12 20 48 67 1,43 0,78 52 63 58
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The	study	included:
–	 repeat	Pap	test	taken	with	Cervex	BrushTM	(630	women).
–	 material	 taken	with	 Cervex	 BrushTM	 on	 liquid	medium	
for	molecular	 identification	of	 	DNA	(558	women)	and	
mRNA	HPV	HR	(421	women).
–	 material	taken	with	Cervex	BrushTM	in	order	to	perform	
tests	 for	 the	 presence	 of	 immunocytochemical	 P16	 and	
Ki67	(86	women).
–	 Colposcopy	with	punch	biopsy	of	suspicious	focal	sites	
or	transition	zone	and	diagnostic	abrasion	of	cervix	(630	
women).	
Methods
Cytodiagnostics	-	Sampling	technique,	fixation,	staining	and	
evaluation	of	smears	by	The	Bethesda	System	was	in	compliance	
with	the	procedure	in	force	in	the	European	Screening	Programs	
and	 Population	 Prevention	 and	 Early	 Detection	 of	 Cervical	
Cancer	implemented	in	Poland	since	2005.	
Colposcopy	–	performed	using	Olympus	optical	colposcopic	
OCS-500	 and	 Leisegang	 3MLW	 and	 documented	 by	 the	
classification	of	the	International	Federation	of	Cervical	Pathology	
and	Colposcopy	in	2003.	Verified	cytological	diagnosis	as	well	
as	molecular	and	immunocytochemical	study	was	carried	out	in	
the	 Laboratory	 of	 Cervical	 Pathophysiology,	 Gynecology	 and	
Obstetrics	Clinical	Hospital,	Karol	Marcinkowski	University	of	
Medical	 Sciences,	 Poznan	 and	 the	Department	 of	Gynecology	
and	Obstetrics	Hospital,	NZOZ	of	St.	Alexandra,	Kielce.	
Molecular	diagnostics	of	HPV	HR	–	molecular	diagnostics	of	
DNA	HPV	HR	–	performed	with	the	use	of	the	Roche	Diagnostics	
COBAS	equipment	X	480,	COBAS	Z	480	which	 identifies	14	
types	of	DNA	HPV	HR.	Molecular	diagnostics	of	mRNA	HPV	
HR	 –	 performed	 with	 the	 use	 of	 the	 Biomerieux	 EAZY	 Q,	
EAZY	MAG	which	 identifies	5	 types	of	mRNA	HPV	HR	(16,	
18,	31,	33,	45).	All	stages	of	molecular	tests	were	performed	in	
the	 Laboratory	 of	 Cervical	 Pathophysiology,	 Gynecology	 and	
Obstetrics	Clinical	Hospital,	Karol	Marcinkowski	University	of	
Medical	Sciences,	Poznan.
Immunocytochemistry	 diagnostics	 –	 performed	 for	
cytological	 preparations	 fixed	 and	 stained	 with	 Papanicolaou	
method	 together	 with	 CINtecPLUSTM	 	 procedures	 of	 mtm-
Cytology	Laboratories	AG.	Suppressor	protein	P16	and	nuclear	
Ki	67	were	being	identified.	All	stages	of	tests	were	performed	
in	the	Laboratory	of	Cervical	Pathophysiology,	Gynecology	and	
Obstetrics	Clinical	Hospital,	Karol	Marcinkowski	University	of	
Medical	Sciences,	Poznan.
Statistical analysis
The	values	of	 the	analyzed	parameters	due	 to	 the	nominal	
measurement	 scale	 were	 characterized	 by	 cardinality	 and	
percentage.	 Differences	 between	 the	 analyzed	 non-measurable	
parameters	 were	 assessed	 in	 multi-way	 tables	 and	 test	 for	
homogeneity	 or	 independence	 χ2.	 To	 evaluate	 the	 existing	
relation,	Ф	factor	was	applied	or	Cramer’s	V	(multi-way	table),	
considering	values	from	0	(no	relation)	to	1	(total	dependence).	
The	usefulness	of	diagnostic	tests	by	calculating	the	sensitivity,	
specificity,	 positive	 predictive	 value,	 negative	 predictive	 value	
and	accuracy	was	evaluated.	5%	inferential	error	was	accepted	
together	with	the	associated	significance	level	p	<0.05	indicating	
a	statistically	significant	difference	or	relation.	
Results
The	 sensitivity	 of	 Pap	 test	 identification	 of	 CIN	 2	 +	 was	
of	85%	and	specificity	of	23%.	 Indicators	PPV	and	NPV	were	
respectively	39%	and	72%.	The	accuracy	of	cytology	reached	a	
level	of	46%.	DNA	HPV	HR	test	obtained	91%	sensitivity	and	
33%	specificity	 of	 the	diagnosis	 of	CIN	2	+.	 Its	 accuracy	was	
54%.	The	value	of	PPV	and	NPV	for	molecular	diagnostics	was	
respectively	43%	and	87%.	For	mRNA	HPV	HR	test	sensitivity	of	
the	method	was	79%,	the	specificity	was	67%.		CINTecPLUSTM 
test	achieved	100%	sensitivity	and	67%	specificity	in	the	diagnosis	
of	CIN	2	+	(Table	I,	Table	II,	Table	III).
Discussion
The	 main	 parameter	 determining	 the	 usefulness	 of	 a	
screening	test	is	its	sensitivity.	After	many	years	of	screening	in	
selected	countries	of	Western	Europe,	70%	-	90%	of	 the	 target	
population	 was	 covered	 by	 regular	 cytological	 examination	
[11].	Recent	decrease	in	morbidity	and	mortality	due	to	cervical	
cancer	 has	 been	 observed	 mainly	 in	 countries	 employing	
extensive	screening	programs.	Nowhere,	however,	the	problems	
associated	with	the	development	of	cervical	pathology	have	been	
completely	solved.		An	example	is	the	Netherlands	where,	since	
2002,	despite	continuous	and	active	screening	programs,	there	is	
no	further	reduction	of	morbidity	and	mortality	due	 to	cervical	
cancer,	which	has	consistently	been	observed	in	previous	years	
[11].	Incidence	rate	“has	stopped”	at	the	value	of	7.3	/	100,000	
women	and	mortality	rate	at	2.3	/	100,000	women.
The	 limitation	 of	 cervical	 cancer	 screening	 tests	 is	 their	
low	sensitivity.	Our	research	based	on	standards	associated	with	
Polish	 programs	 of	 prevention	 and	 early	 detection	 of	 cervical	
cancer.	Obtained	in	the	course	of	the	present	study,	the	sensitivity	
of	 conventional	 cytodiagnosis	 used	 for	 detection	 of	 CIN	 2	 +	
reached	85%.
This	result	is	comparable	or	even	higher	than	that	reported	
by	 other	 laboratories,	 where	 the	 sensitivity	 of	 identification	
of	CIN	2	+	 ranges	 from	30%	 to	 70%	 [2,	 3].	Without	 a	 doubt,	
the	 effectiveness	 of	 cytodiagnosis	 detection	 system	 decreases	
significantly	for	cytological	diagnosis	endowed	with	a	higher	risk	
of	misidentification	of	precancerous	 changes	 such	as	ASC-US.	
For	this	cytological	diagnosis,	sensitivity	of	detection	of	cervical	
pathology,	regardless	of	its	degree	of	severity	was	only	67%	and	
specificity	was	33%.	
Broad,	 multi-center	 meta-analysis	 published	 in	 2006	
concluded	 that	 the	 sensitivity	 of	 pathology	 detection	 for	 the	
cytological	diagnosis	of	ASC-US	was	53%	while	specificity	was	
similar	to	that	obtained	in	the	present	study	[2,	3].	
The	 obtained	 cytodiagnostic	 parameters	 of	 sensitivity	
and	 specificity	 of	 cervical	 pathology	 indicate	 a	 significant	 risk	
of	 false	negative	and	 false	positive	 results.	The	 low	specificity	
(not	 exceeding	 33%)	 of	ASC-US	 diagnosis	 is	 associated	 with	
excessive	 number	 of	 unnecessary	 and	 expensive	 verifying	
medical	 diagnostic	 procedures	 –	 colposcopies.	 A	 solution	 is	
problem	currently	implemented	for	screening	in	the	world,	is	the	
use	of	objective	molecular	diagnostic	of	HPV	infection.
Verification	of	ASC-US	diagnosis	by	performing	a	 test	 for	
the	 presence	 of	 at	 least	 14	 types	 of	HPV	 is	 now	 the	 so-called	
standard	 of	 care,	 including	 extensive	 screening.	 In	 study	 tests,	
carried	out	in	terms	of	this	paper,	the	sensitivity	of	the	molecular	
identification	 of	 DNA	 HPV	 in	 cervical	 pathology	 was	 91%	
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and	 was	 significantly	 higher	 compared	 to	 the	 sensitivity	 of	
cytodiagnostic.	The	results	are	consistent	with	reports	published	
by	other	research	centers.	According	to	meta-analysis	from	2002,	
the	sensitivity	of	molecular	detection	of	DNA	HPV	in	cervical	
pathology	CIN	 2	 +	was	 of	 96.1%	 and	 specificity	 of	 90.7%.	 It	
should	be	noted	that	this	specificity	is	considerably	reduced	if	the	
study	test	includes	women	at	the	age	of	30,	and	reaches	76.5%	
[1].	Specificity	of	molecular	diagnostics	increases	with	age	of	the	
population	studied	and	reaches	95.5%	for	women	over	30	years	
of	age	[9].	Very	interesting	is	molecular	diagnostic	accuracy	in	
the	detection	of	cervical	pathology.	Its	value	is	70%	and	is	higher	
than	accuracy	of	cytodiagnostics	in	detecting	the	type	of	LG	SIL	
(58%)	and		accuracy	for	detecting	HG	SIL	(48%).
High	value	(NPV)	of	87%	for	DNA	HPV	testing	was	also	
the	highest	obtained	NPV	score	in	all	the	studies,	except	for	the	
immunocytochemical	 method.	 The	 present	 study	 demonstrates	
that	the	identification	of	transcripts	of	five	oncogenic	HPV	types	
is	associated	with	72%	pure	sensitivity	and	67%	specificity	in	the	
detection	of	cervical	pathology.	The	sensitivity	of	mRNA	HPV	
test	is	higher	for	changes	of	HG	SIL	or	CIN2	+,	reaching	a	value	
of	79%.
Very	 similar	 results	 were	 obtained	 by	 Keegan	 et	 al,	 who	
assessed	the	sensitivity	of	determination	of	transcripts	in	detecting	
cervical	 pathology	 at	 71.4%	 [5].	 Lower	 sensitivity(63%)	 was	
described	by		Halfon	et	al,	using	the	assay	to	detect	transcripts	
of	 CIN	 2	 +	 [4].	Assuming	 the	 same	 assumptions,	 Sorby	 et	 al	
showed	81%	sensitivity	and	97%	NP,	for	the	diagnosis	of	mRNA	
HPV	[13].	As	a	result	of	studies	which	represent	the	object	of	this	
paper,	 it	was	 found	 that	 the	CINTecPlusTM	 test	 has	 the	highest	
accuracy	in	identify		CIN	2	+		(78%)	and	its	sensitivity	is	set	to	
100%,	compared	to	all	analyzed	methods.
	These	 results	are	consistent	with	 those	of	other	published	
results,	 evaluating	 the	 sensitivity	 of	 CINTecPlusTM	 in	 the	
identification	of	CIN	3,	from	81%	to	100%	and	specificity	from	
60%	to	75%	[10].	Szarewski	et	al	showed	92.7%	sensitivity	and	
65.8%	specificity	of	detection	of	CIN	2	+	by	CINTecPlusTM	test	
[12].	In	conclusions,	the	comparative	analysis	of	different	methods	
for	 the	 detection	 of	 cervical	 pathology	 showed	 a	 significant	
advantage	 for	 both	 molecular	 HPV	 testing	 and	 conventional	
immunohistochemistry	 on	 cytodiagnostics.	 These	 results	 are	
consistent	 with	 those	 of	 other	 published	 results	 on	 sensitivity	
of	CINTecPlusTM	in	the	identification	of	CIN	3	reaching	81%	to	
100%	and	specificity	of	75%	to	60%	[10].	Szarewski	et	al	showed	
92.7%	sensitivity	and	65.8%	specificity	of	detection	of	CIN	2	+	by	
CINTecPlusTM	test	[12].	To	conclude,	the	comparative	analysis	of	
different	methods	for	the	detection	of	cervical	pathology	showed	
a	significant	advantage	for	both	molecular	DNA	HPV	testing	and	
conventional	immunohistochemistry	over	cytodiagnostics.
It	was	apparent	in	detecting	changes	in	LG	SIL	and	HG	SIL,	
the	analysis	of	sensitivity,	specificity	and	accuracy	of	particular	
method.	 Conventional	 cytodiagnostics	 has	 demonstrated	 its	
superiority	 over	 mRNA	 HPV	 test	 in	 terms	 of	 specificity	 for	
changes	of	LG	SIL	and	HG	SIL.	There	isevidence	that	testing	only	
5-five	types	of	HPV	is	insufficient.	Based	on	available	studies,	it	
can	be	concluded	that	in	the	near	future	screening	should	include	
modified	 cytodiagnosis	 and	 immunocytochemical	 detection	
markers	 of	 carcinogenesis	 with	 special	 emphasis	 on	 p16INK4a 
tumor	 suppressor	protein	 and	nuclear	 factor	Ki-67.	The	 results	
presented	 in	 this	 study,	 along	 with	 other	 relevant	 publications	
create	 an	 	 opportunity	 for	 the	 immunocytochemical	method	 to	
gradually	 replace	 traditional	 cytodiagnostics	 in	 cervical	 cancer	
screening.
Conclusions
	Conventional	cytodiagnostics	are	inferior	in	terms	of	both	1.	
sensitivity	and	specificity	to	molecular	test	for	DNA,	mRNA	
HPV	HR	and	immunocytochemical	tests	for	detecting	LG	
SIL	and	HG	SIL.
	Immunocytochemical	 technique	 shows	 maximum	2.	
sensitivity	 and	 high	 specificity	 of	 detection	 of	 actual	
precancerous	stages	-	CIN	2	+.
References 
  1. Bosch F, Lorincz A, Munoz N, [et al.]. The casual relation between human papillomavirus and 
cervical cancer. J Clin Patrol. 2002, 55, 244-265.
  2.  Cuzik J, Szarewski A, Cubie H, [et al.]. Management of woman who test positive for high risk 
types of human papilloma virus. The Hart Study. Lancet. 2003, 362, 1871-1876.
  3.  Cuzik J, Clavel C, Petry K, [et al.]. Overview of the European and North American studies on 
HPV testing in primary cervical cancer screening. Int J Cancer. 2006, 119, 1095-1105.
  4.  Halfon P, Benmoura D, Agostini A, [et al.]. Relevance of HPV mRNA detection in a population of 
ASC-US plus women using Nuclisens EasyQ HPV assay. J Clin Virol. 2010, 47, 177-181.
  5.  Keegan H, Inerney J, Pilkington L, [et al.]. Comparison of HPV detection technologies: Hybrid 
Capture 2, PreTectTM HPV Proofer and analysis of HPV DNA viral load in HPV 16, HPV 18 and 
HPV 33 E6/E7 mRNA positive specimens. J Virology Methods. 2009, 155, 61-66.
  6.  Kędzia W, Goździcka-Józefiak A. Mechanizm kancerogenezy zachodzący w komórkach 
nabłonka paraepidermalnego szyjki macicy zakażonych przewlekle onkogennymi typami wirusa 
brodawczaka ludzkiego. Ginekol Pol. 2007, 78, 701-708.
  7.  Rokita W. Miejsce Kolposkopii w Populacyjnym Programie Profilaktyki i Wczesnego Wykrywania 
Raka Szyjki macicy. Ginekol Pol. 2007, 78 719-722.
  8.  Spaczyński M, Kotarski J, Nowak- Markwitz E, [i wsp.]. Postępowanie w przypadku 
nieprawidłowego wyniku przesiewowego badania cytologicznego. Rekomendacje COK Popu-
lacyjny Program Profilaktyki i Wczesnego Wykrywania raka Szyjki macicy, PTG, PTP i Polskiego 
Towarzystwa Kolposkopii i Patofizjologii Szyjki Macicy. Ginekol Pol. 2009, 80, 134-138.
  9.  Walboomers J, Jacobs M, Manos M, [et al.]. Human papillomavirus is a necessary cause of 
invasive cervical cancer worldwide. J Pathol. 1999, 189, 12-19.
10.  Wentzesen N, Bergeron C, Cas F, [et al.]. Triage of women with ASC-US and LSIL cytology : use 
of qualitative assessment of p16 INK4a positive cells to identify patients with high grade cervical 
intraepithelial neoplasia. Cancer. 2007, 111, 58-66.
11.  WHO/ICO Information Centre on HPV and Cervical Cancer. HPV and cervical cancer in the 
world 2007 report. Vaccine. 2007, 25, suppl 3, 1-230.
12.  Szarewski A, Ambroisine L, Cadman I, [et al.]. Comparison of predictors for high-grade cervical 
intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev. 
2008, 17, 3033-3042.
13.  Sorbye S, Fismen S, Gutteberg T, [et al.]. HPV mRNA test in women with minor cervical lesions: 
Experience of the University Hospital of North Norway. Journal of Virological Methods. 2010, 
169, 219-222.
